Filing Details
- Accession Number:
- 0001562180-19-003585
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-18 17:18:54
- Reporting Period:
- 2019-06-17
- Accepted Time:
- 2019-06-18 17:18:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1690585 | Magenta Therapeutics Inc. | MGTA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1741288 | P. Michael Cooke | C/O Magenta Therapeutics, Inc. 100 Technology Square, 5Th Floor Cambridge MA 02139 | Chief Scientific Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-06-17 | 7,500 | $13.90 | 285,523 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This trade is pursuant to an active 10b5-1 plan.
- This transaction was executed in multiple trades at prices ranging from $13.72 to $14.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.